Evidence for low high-density lipoprotein cholesterol levels in Australian indigenous peoples: A systematic review

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Lyons, Jasmine G ^a,b,c   O'Dea, Kerin ^b,c   Walker, Karen Z ^a,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Australian Aborigines; Cardiometabolic; Cardiovascular disease; Cardiovascular disease risk factors; Dyslipidaemia; High density lipoprotein cholesterol; Indigenous; Lipids; Non communicable disease; Torres Strait Islanders

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AUSTRALIA; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; OBESITY; OCEANIC ANCESTRY GROUP; PREVALENCE; RISK FACTOR; RURAL POPULATION; STATISTICS AND NUMERICAL DATA;

AUSTRALIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DIABETES MELLITUS; DYSLIPIDEMIAS; HUMANS; OBESITY; OCEANIC ANCESTRY GROUP; PREVALENCE; RISK FACTORS; RURAL POPULATION;

EID: 84903519588     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-545     Document Type: Review

References (62)

1. Burden of disease and injury in Aboriginal and Torres Strait islander peoples: the indigenous health gap. Vos T, Barker B, Begg S, Stanley L, Lopez AD, Int J Epidemiol 2009 38 470 477 10.1093/ije/dyn240 19047078
2. The health and welfare of Australia's Aboriginal and Torres Strait Islander people, an overview 2011. Australian Institute of Health and Welfare, Book The health and welfare of Australia's Aboriginal and Torres Strait Islander people, an overview 2011 City: Australian Institute of Health and Welfare 2011
3. The metabolic syndrome and changing relationship between blood pressure and insulin with age, as observed in Aboriginal and Torres Strait islander peoples. Schutte AE, Shemesh T, Rowley K, Best JD, McDermott R, O'Dea K, Diabet Med 2005 22 1589 1597 10.1111/j.1464-5491.2005.01747.x 16241926
4. The metabolic syndrome and CVD outcomes for a central Australian cohort. Luke JN, Brown A, Daniel M, O'Dea K, Best JD, Jenkins AJ, Wang Z, McDermott RA, Wang Z, Rowley KG, Diabetes Res Clin Pract 2013 100 70 e73 10.1016/j.diabres. 2013.03.020 23540681
5. Non-communicable diseases, infection and survival in a retrospective cohort of indigenous and non-indigenous adults in central Australia. Einsiedel L, Fernandes L, Joseph S, Brown A, Woodman RJ, BMJ Open 2013 3 7 003070 23872293
6. Acute rheumatic fever and rheumatic heart disease: an insight into Aboriginal health disadvantage and remote Australia. Maguire GP, Nelson C, Med J Aust 2006 184 506 16719749
7. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ, J Hosp Infect 1998 38 273 281 10.1016/S0195-6701(98)90076-7 9602976
8. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community. McDonald S, Maguire G, Duarte N, Wang XL, Hoy W, Clin Sci (Lond) 2004 106 121 128 10.1042/CS20030186 12956621
9. Risk factors for ill-health in a remote desert-dwelling aboriginal community in Western Australia. Gracey M, Spargo RM, Smith P, Smith RM, Burke V, Beilin LJ, Beilby J, Chin C, Aust NZ J Med 1996 26 171 179 10.1111/j.1445-5994. 1996.tb00881.x
10. Two nations: racial disparities in bloodstream infections recorded at Alice Springs Hospital, central Australia, 2001-2005. Einsiedel LJ, Woodman RJ, Med J Aust 2010 192 567 571 20477732
11. Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review. Chirovsky DR, Fedirko V, Cui Y, Sazonov V, Barter P, Eur J Cardiovasc Prev Rehabil 2009 16 404 423 10.1097/HJR.0b013e32832c8891 19465856
12. Cholesterol and atherosclerosis: modulation by oestrogen. Barton M, Curr Opin Lipidol 2013 24 214 220 10.1097/MOL.0b013e3283613a94 23594711
13. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Kontush A, Chapman MJ, Pharmacol Rev 2006 58 342 374 10.1124/pr.58.3.1 16968945
14. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
15. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Alberti KG, Zimmet P, Shaw J, Diabet Med 2006 23 469 480 10.1111/j.1464-5491.2006.01858.x 16681555
16. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgozoglu L, Tybjaerg-Hansen A, Watts GF, European Atherosclerosis Society Consensus Panel, Eur Heart J 2011 32 1345 1361 10.1093/eurheartj/ehr112 21531743
17. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management - 2005. Tonkin A, Barter P, Best J, Boyden A, Furler J, Hossack K, Sullivan D, Thompson P, Vale M, Cooper C, Robinson M, Clune E, National Heart Foundation of Australia, Cardiac Society of Australia and New Zealand, Heart Lung Circ 2005 14 275 291 16361000
18. Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesaniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM, Am J Cardiol 2005 95 194 198 10.1016/j.amjcard.2004.08.091 15642551
19. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, et al. Eur Heart J 2007 28 2375 2414 17726041
20. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia. Shemesh T, Rowley KG, Jenkins A, Brimblecombe J, Best JD, O'Dea K, Int J Obes (Lond) 2007 31 103 108 10.1038/sj.ijo.0803350 16682979
21. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Rowley K, Walker KZ, Cohen J, Jenkins AJ, O'Neal D, Su Q, Best JD, O'Dea K, Med J Aust 2003 178 495 500 12741936
22. Increase in prevalence of obesity and diabetes and decrease in plasma cholesterol in a central Australian aboriginal community. McDermott R, Rowley KG, Lee AJ, Knight S, O'Dea K, Med J Aust 2000 172 480 484 10901770
23. Abnormal glucose tolerance and other coronary heart disease risk factors in an isolated aboriginal community in central Australia. Gault A, O'Dea K, Rowley KG, McLeay T, Traianedes K, Diabetes Care 1996 19 1269 1273 10.2337/diacare.19.11.1269 8908393
24. Hemostatic factors in Australian Aboriginal and Torres Strait islander populations. Wang Z, Rowley K, Best J, McDermott R, Taylor M, O'Dea K, Metab Clin Exp 2007 56 629 635 10.1016/j.metabol.2006.12.009 17445537
25. Australian Aboriginal people and Torres Strait islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles. O'Neal DN, Piers LS, Iser DM, Rowley KG, Jenkins AJ, Best JD, O'Dea K, Atherosclerosis 2008 201 368 377 10.1016/j.atherosclerosis.2008.03. 022 18599067
26. Impact of Westernization on carbohydrate and lipid metabolism in Australian Aborigines. O'Dea K, Spargo RM, Nestel PJ, Diabetologia 1982 22 148 153 7075914
27. Exploring clinical predictors of cardiovascular disease in a central Australian Aboriginal cohort. Luke JN, Brown AD, Brazionis L, O'Dea K, Best JD, McDermott RA, Wang Z, Wang Z, Rowley KG, Eur J Prev Cardiol 2013 20 246 253 10.1177/2047487312437713 22345691
28. Large waist but low body mass index: the metabolic syndrome in Australian Aboriginal children. Sellers EA, Singh GR, Sayers SM, J Pediatr 2008 153 222 227 10.1016/j.jpeds.2008.02.006 18534223
29. Low high-density lipoprotein-cholesterol is the most prevalent metabolic abnormality for Australian Aboriginal men and women even when lean. Shemesh T, Rowley KG, Piers LS, Best JD, O'Dea K, Eur J Cardiovasc Prev Rehabil 2008 15 49 51 10.1097/HJR.0b013e3282f0e327 18277185
30. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Sanderson S, Tatt ID, Higgins JP, Int J Epidemiol 2007 36 666 676 10.1093/ije/dym018 17470488
31. Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE, Int J Obes Relat Metab Disord 2004 28 402 409 10.1038/sj.ijo.0802567 14724659
32. Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations. Li M, McDermott RA, Diabetes Res Clin Pract 2010 87 401 406 10.1016/j.diabres.2009.12.004 20034692
33. Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit. Peiris DP, Patel AA, Cass A, Howard MP, Tchan ML, Brady JP, De Vries J, Rickards BA, Yarnold DJ, Hayman NE, Brown AD, Med J Aust 2009 191 304 309 19769551
34. Determinants of carotid intima-medial thickness in an urban Australian Aboriginal population. Bradshaw PJ, Wilkes ET, Thompson PL, Atherosclerosis 2007 192 218 223 10.1016/j.atherosclerosis.2006.05.013 16860327
35. Diabetes and cardiovascular risk factors in urban indigenous adults: results from the DRUID study. O'Dea K, Cunningham J, Maple-Brown L, Weeramanthri T, Shaw J, Dunbar T, Zimmet P, Diabetes Res Clin Pract 2008 80 483 489 10.1016/j.diabres.2008.02.008 18359533
36. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Wang Z, Hoy WE, Med J Aust 2005 182 66 69 15651963
37. Diabetes, hyperinsulinemia, and hyperlipidemia in small aboriginal community in northern Australia. O'Dea K, Lion RJ, Lee A, Traianedes K, Hopper JL, Rae C, Diabetes Care 1990 13 830 835 10.2337/diacare.13.8.830 2209316
38. Obesity, diabetes, and hyperlipidemia in a central Australian aboriginal community with a long history of acculturation. O'Dea K, Patel M, Kubisch D, Hopper J, Traianedes K, Diabetes Care 1993 16 1004 1010 10.2337/diacare.16.7. 1004 8359092
39. Blood pressure, lipids and other risk factors for cardiovascular disease in Aborigines and persons of European descent of southeastern Australia. Guest CS, O'Dea K, Larkins RG, Aust J Public Health 1994 18 79 86 8068802
40. Diabetes prevalence and determinants in Indigenous Australian populations: a systematic review. Minges KE, Zimmet P, Magliano DJ, Dunstan DW, Brown A, Shaw JE, Diabetes Res Clin Pract 2011 93 139 149 10.1016/j.diabres. 2011.06.012 21742398
41. C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort. Shemesh T, Rowley KG, Jenkins AJ, Best JD, O'Dea K, Clin Chem 2009 55 336 341 19074519
42. Fibrinogen and associated risk factors in a high-risk population: urban indigenous Australians, the DRUID Study. Maple-Brown LJ, Cunningham J, Nandi N, Hodge A, O'Dea K, Cardiovasc Diabetol 2010 9 69 10.1186/1475-2840-9-69 21029470
43. Similarities and differences in cardiometabolic risk factors among remote Aboriginal Australian and Canadian cohorts. Maple-Brown LJ, Brimblecombe J, Connelly PW, Harris SB, Mamakeesick M, Zinman B, O'Dea K, Hanley AJ, Diabetes Res Clin Pract 2013 100 133 141 10.1016/j.diabres.2012.12.017 23312484
44. Abdominal obesity and other risk factors largely explain the high CRP in indigenous Australians relative to the general population, but not gender differences: a cross-sectional study. Hodge AM, Maple-Brown L, Cunningham J, Boyle J, Dunbar T, Weeramanthri T, Shaw J, O'Dea K, BMC Public Health 2010 10 700 10.1186/1471-2458-10-700 21078191
45. Serum C-reactive protein as a marker for wellness assessment. Kao PC, Shiesh SC, Wu TJ, Ann Clin Lab Sci 2006 36 163 169 16682512
46. A health profile of adults in a Northern territory aboriginal community, with an emphasis on preventable morbidities. Hoy WE, Norman RJ, Hayhurst BG, Pugsley DJ, Aust N Z J Public Health 1997 21 121 126 10.1111/j.1467-842X.1997. tb01670.x 9161065
47. The health of urban Aboriginal people: insufficient data to close the gap. Eades SJ, Taylor B, Bailey S, Williamson AB, Craig JC, Redman S, Investigators S, Med J Aust 2010 193 521 524 21034386
48. The Australian diabetes, obesity and lifestyle study (AusDiab)-methods and response rates. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, Jolley D, McCarty DJ, Australian Diabetes O, Diabetes Res Clin Pract 2002 57 119 129 10.1016/S0168-8227(02)00025-6 12062857
49. Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the greater green triangle risk factor study. Janus ED, Tideman PA, Dunbar JA, Kilkkinen A, Bunker SJ, Philpot B, Tirimacco R, Mc Namara K, Heistaro S, Laatikainen T, Med J Aust 2010 192 127 132 20121678
50. Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease. Peloso GM, Demissie S, Collins D, Mirel DB, Gabriel SB, Cupples LA, Robins SJ, Schaefer EJ, Brousseau ME, J Lipid Res 2010 51 3524 3532 10.1194/jlr.P008268 20855565
51. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F, Exp Gerontol 2009 44 136 160 10.1016/j.exger.2008.11.003 19041386
52. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype. Mahley RW, Pepin J, Palaoglu KE, Malloy MJ, Kane JP, Bersot TP, J Lipid Res 2000 41 1290 1301 10946017
53. Genetic studies of human apolipoproteins. XX. Genetic polymorphism of apolipoprotein J and its impact on quantitative lipid traits in normolipidemic subjects. Kamboh MI, Harmony JA, Sepehrnia B, Nwankwo M, Ferrell RE, Am J Hum Genet 1991 49 1167 1173 1746550
54. Apolipoprotein E polymorphism in indigenous Australians: allelic frequencies and relationship with dyslipidaemia. Shaw JT, Tate J, Kesting JB, Marczak M, Berkholz JR, Lovelock PK, Purdie D, Hickman P, Cameron DP, Med J Aust 1999 170 161 164 10078180
55. Early life influences on cardio-metabolic disease risk in aboriginal populations-what is the evidence? A systematic review of longitudinal and case-control studies. McNamara BJ, Gubhaju L, Chamberlain C, Stanley F, Eades SJ, Int J Epidemiol 2012 41 1661 1682 10.1093/ije/dys190 23211415
56. Ethnic difference in sex gap in high-density lipoprotein cholesterol between Asian Indians and Whites. Chandalia M, Mohan V, Adams-Huet B, Deepa R, Abate N, J Investig Med 2008 56 574 580 18418125
57. Cardiovascular disease and risk factors among 345 adults in rural India-the Andhra Pradesh rural health initiative. Chow C, Cardona M, Raju PK, Iyengar S, Sukumar A, Raju R, Colman S, Madhav P, Raju R, Reddy KS, Celermajer D, Neal B, Int J Cardiol 2007 116 180 185 10.1016/j.ijcard.2006.03.043 16839628
58. High prevalence of metabolic syndrome & its correlates in two tribal populations of India & the impact of urbanization. Sarkar S, Das M, Mukhopadhyay B, Chakrabarti C, Majumder PP, Indian J Med Res 2006 123 679 686 16873911
59. Modernization of lifestyle, body fat content and body fat distribution: a comparison of Igloolik Inuit and Volochanka nGanasan. Rode A, Shephard RJ, Int J Obes Relat Metab Disord 1995 19 709 716 8589764
60. Cardiometabolic risk and disease in Indigenous Australians: the heart of the heart study. Brown A, Carrington MJ, McGrady M, Lee G, Zeitz C, Krum H, Rowley K, Stewart S, Int J Cardiol 2014 171 377 383 10.1016/j.ijcard.2013.12.026 24388543
61. Are hygiene and public health interventions likely to improve outcomes for Australian Aboriginal children living in remote communities? A systematic review of the literature. McDonald E, Bailie R, Brewster D, Morris P, BMC Public Health 2008 8 153 10.1186/1471-2458-8-153 18462504
62. Lipid profiles and persisting inflammation following critical illness in a central Australian population: a prospective longitudinal observational study. Secombe PJ, Brown A, Kruger PS, Stewart PC, Intern Med J 2013 43 445 449 10.1111/imj.12086 23551307